Michel Dahan - Feb 29, 2024 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
SVP, Chief Operating Officer
Signature
/s/ Carolyn Rucci, attorney-in-fact for Michel Dahan
Stock symbol
AKBA
Transactions as of
Feb 29, 2024
Transactions value $
-$13,684
Form type
4
Date filed
3/1/2024, 05:49 PM
Previous filing
Feb 29, 2024
Next filing
May 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale -$13.7K -8.66K -1.21% $1.58 707K Feb 29, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.